The move would onshore production of its rare disease products at an existing facility in Frederick and build a clinical research drug factory in Gaithersburg.
Categories:
Related Post
Military research facilities falling into disrepair, report says
Aging infrastructure is hampering the country’s ability to maintain a technically advanced warfighting capability, says…
Balfour Beatty invests nearly $10M in Microsoft AI
As part of the initiative, the London-based builder will pilot an artificial intelligence agent on…
Fluor, Balfour Beatty complete $677M Texas highway project
Five years after construction broke ground, the JV marked the opening of the Oak Hill…